-

ResMed (RMD) Product Pipeline Analysis Report 2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "ResMed Inc (RMD) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

ResMed Inc (ResMed) is a medical device company. It develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include airflow generators such as continuous positive airway pressure (CPAP) devices, auto-bilevel devices, variable positive airway pressure (VPAP) devices, and automatic positive airway pressure (APAP) devices.

The company distributes its products in various countries through a combination of distributors and direct sales teams. ResMed also offers software as a service (SaaS) to out-of-hospital health providers. The company sells its products to sleep clinics, home healthcare dealers, and third-party payers. ResMed is headquartered in San Diego, California, the US.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Report Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ResMed Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

ResMed Inc, Recent Developments

  • Dec 19, 2025: ResMed Receives FDA 510(k) Clearance for Personalized Therapy Comfort Settings (PTCS)
  • Dec 08, 2025: Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
  • Nov 19, 2025: Abigail Uttley Joins Inhealthcare as Project Manager
  • Oct 13, 2025: Fractus Files Patent Infringement Complaint Against ResMed in Southern District of California
  • Oct 01, 2025: Amy Frith Appointed Customer Success Manager for NHS Digital Health Partnerships at Inhealthcare
  • Sep 03, 2025: Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
  • Aug 21, 2025: Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
  • Aug 18, 2025: Resmed Appoints Nicole Mowad-Nassar to Board of Directors
  • Jul 21, 2025: Oxygen Therapy Devices Market Set for Steady Expansion by 2032, Driven by Fisher & Paykel Healthcare, Masimo, Vapotherm, BMC Medical, ResMed, Allied Medical, Hamilton Medical, Neote
  • Jun 10, 2025: ResMed Receives Additional 510(K) Clearance For AirFit F20

Key Topics Covered:

  • ResMed Inc Company Overview
  • ResMed Inc Company Snapshot
  • ResMed Inc Pipeline Products and Ongoing Clinical Trials Overview
  • ResMed Inc - Pipeline Analysis Overview
  • Business Description
  • ResMed Inc - Key Facts
  • ResMed Inc - Major Products and Services
  • ResMed Inc Pipeline Products by Development Stage
  • ResMed Inc Ongoing Clinical Trials by Trial Status
  • ResMed Inc Pipeline Products Overview
  • AirCurve 11 ASV - Insomnia
  • AirCurve 11 ASV - Insomnia Product Overview
  • AirCurve 11 ASV - Insomnia Clinical Trial
  • AirFit F40
  • AirFit F40 Product Overview
  • Breezhaler Inhaler - Add On Sensor
  • Breezhaler Inhaler - Add On Sensor Product Overview
  • Connected Metered Dose Inhaler
  • Connected Metered Dose Inhaler Product Overview
  • Leo
  • Leo Product Overview
  • Masksense
  • Masksense Product Overview
  • Mitigait
  • Mitigait Product Overview
  • Monterey Pneumatic Compression Device
  • Monterey Pneumatic Compression Device Product Overview
  • Personalized Therapy Comfort Settings (PTCS)
  • Personalized Therapy Comfort Settings (PTCS) Product Overview
  • Smart Device - Cardiac Health
  • Smart Device - Cardiac Health Product Overview
  • ResMed Inc - Key Competitors
  • ResMed Inc - Key Employees
  • ResMed Inc - Key Employee Biographies
  • ResMed Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Appendix

For more information about this company profile visit https://www.researchandmarkets.com/r/x0z25

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Hexabromocyclododecane provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a v...

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...
Back to Newsroom